246 related articles for article (PubMed ID: 28277880)
1. Genomic tests to guide prostate cancer management following diagnosis.
Colicchia M; Morlacco A; Cheville JC; Karnes RJ
Expert Rev Mol Diagn; 2017 Apr; 17(4):367-377. PubMed ID: 28277880
[TBL] [Abstract][Full Text] [Related]
2. Genomic Markers in Prostate Cancer Decision Making.
Cucchiara V; Cooperberg MR; Dall'Era M; Lin DW; Montorsi F; Schalken JA; Evans CP
Eur Urol; 2018 Apr; 73(4):572-582. PubMed ID: 29129398
[TBL] [Abstract][Full Text] [Related]
3. An overview of biomarkers in the diagnosis and management of prostate cancer.
Uhr A; Glick L; Gomella LG
Can J Urol; 2020 Aug; 27(S3):24-27. PubMed ID: 32875999
[TBL] [Abstract][Full Text] [Related]
4. Unfavorable Pathology, Tissue Biomarkers and Genomic Tests With Clinical Implications in Prostate Cancer Management.
Nguyen JK; Magi-Galluzzi C
Adv Anat Pathol; 2018 Sep; 25(5):293-303. PubMed ID: 29727322
[TBL] [Abstract][Full Text] [Related]
5. Which, when and why? Rational use of tissue-based molecular testing in localized prostate cancer.
Ross AE; D'Amico AV; Freedland SJ
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):1-6. PubMed ID: 26123120
[TBL] [Abstract][Full Text] [Related]
6. Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline.
Eggener SE; Rumble RB; Armstrong AJ; Morgan TM; Crispino T; Cornford P; van der Kwast T; Grignon DJ; Rai AJ; Agarwal N; Klein EA; Den RB; Beltran H
J Clin Oncol; 2020 May; 38(13):1474-1494. PubMed ID: 31829902
[TBL] [Abstract][Full Text] [Related]
7. Genomic Predictors of Outcome in Prostate Cancer.
Boström PJ; Bjartell AS; Catto JW; Eggener SE; Lilja H; Loeb S; Schalken J; Schlomm T; Cooperberg MR
Eur Urol; 2015 Dec; 68(6):1033-44. PubMed ID: 25913390
[TBL] [Abstract][Full Text] [Related]
8. Novel biomarkers and genomic tests in prostate cancer: a critical analysis.
Falzarano SM; Ferro M; Bollito E; Klein EA; Carrieri G; Magi-Galluzzi C
Minerva Urol Nefrol; 2015 Sep; 67(3):211-31. PubMed ID: 26054411
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers in prostate cancer - Current clinical utility and future perspectives.
Kretschmer A; Tilki D
Crit Rev Oncol Hematol; 2017 Dec; 120():180-193. PubMed ID: 29198331
[TBL] [Abstract][Full Text] [Related]
10. [Molecular biomarkers and prognostic factors for prostate cancer].
Kretschmer A; Tolkach Y; Ellinger J; Kristiansen G
Urologe A; 2017 Jul; 56(7):933-944. PubMed ID: 28573413
[TBL] [Abstract][Full Text] [Related]
11. Genomic Strategies to Personalize Use of Androgen Deprivation Therapy With Radiotherapy.
Glicksman RM; Berlin A
Cancer J; 2020; 26(1):13-20. PubMed ID: 31977380
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic associations of gene expression signatures in prostate cancer tissue.
Nguyen HG; Welty CJ; Cooperberg MR
Curr Opin Urol; 2015 Jan; 25(1):65-70. PubMed ID: 25405934
[TBL] [Abstract][Full Text] [Related]
13. Genomic testing for localized prostate cancer: where do we go from here?
Loeb S; Ross AE
Curr Opin Urol; 2017 Sep; 27(5):495-499. PubMed ID: 28661898
[TBL] [Abstract][Full Text] [Related]
14. Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics.
Moschini M; Spahn M; Mattei A; Cheville J; Karnes RJ
BMC Med; 2016 Apr; 14():67. PubMed ID: 27044421
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer genomics: comparing results from three molecular assays.
Alam S; Tortora J; Staff I; McLaughlin T; Wagner J
Can J Urol; 2019 Jun; 26(3):9758-9762. PubMed ID: 31180305
[TBL] [Abstract][Full Text] [Related]
16. A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.
Klein EA; Yousefi K; Haddad Z; Choeurng V; Buerki C; Stephenson AJ; Li J; Kattan MW; Magi-Galluzzi C; Davicioni E
Eur Urol; 2015 Apr; 67(4):778-86. PubMed ID: 25466945
[TBL] [Abstract][Full Text] [Related]
17. Commercialized biomarkers: new horizons in prostate cancer diagnostics.
Murphy L; Prencipe M; Gallagher WM; Watson RW
Expert Rev Mol Diagn; 2015 Apr; 15(4):491-503. PubMed ID: 25711191
[TBL] [Abstract][Full Text] [Related]
18. Genomic Tests Should be Used to Help Guide Treatment of Prostate Cancer: Yes.
Palapattu GS
J Urol; 2017 Aug; 198(2):265-266. PubMed ID: 28629664
[No Abstract] [Full Text] [Related]
19. Genetic testing for the clinician in prostate cancer.
López-Campos F; Linares-Espinós E; Maldonado Pijoan X; Sancho Pardo G; Morgan TM; Martínez-Ballesteros C; Martínez-Salamanca J; Couñago F
Expert Rev Mol Diagn; 2020 Sep; 20(9):933-946. PubMed ID: 32885704
[TBL] [Abstract][Full Text] [Related]
20. Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men.
Ross AE; Johnson MH; Yousefi K; Davicioni E; Netto GJ; Marchionni L; Fedor HL; Glavaris S; Choeurng V; Buerki C; Erho N; Lam LL; Humphreys EB; Faraj S; Bezerra SM; Han M; Partin AW; Trock BJ; Schaeffer EM
Eur Urol; 2016 Jan; 69(1):157-65. PubMed ID: 26058959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]